Industry: Medical Devices & Consumables
Published Date: 2025-08-05
Pages: 153 Pages
Report ld: 4893918
Request Sample
Customized Report
The global ICSI Injection Micropipettes market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
ICSI injection micropipettes are specialized, fine-tipped glass pipettes used in the intracytoplasmic sperm injection (ICSI) procedure, a common technique in in vitro fertilization (IVF). These micropipettes are meticulously crafted to have extremely fine and precise tips that can capture and inject a single sperm cell directly into an oocyte (egg cell) under a microscope. The delicate nature and precision of these micropipettes are crucial for minimizing damage to the egg during the injection process, thereby increasing the chances of successful fertilization. ICSI injection micropipettes are essential tools for embryologists, enabling them to perform the highly controlled and precise manipulations required in assisted reproductive technologies.
From a downstream perspective, Fertility Clinics accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
ICSI Injection Micropipettes leading manufacturers including Kitazato, Vitrolife, Synga, Microtech, Sunlight Medical, Origio (CooperSurgical), Hamilton Thorne, Cook Medical, BioMedical Instruments, ASTEC Pipette, etc., dominate supply; the top five capture approximately % of global revenue, with Kitazato leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global ICSI Injection Micropipettes market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the ICSI Injection Micropipettes study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to ICSI Injection Micropipettes: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global ICSI Injection Micropipettes Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Blunt Pipettes
1.2.3 Sharp Pipettes
1.2.4 Combination Pipettes
1.3 Market Segmentation by Application
1.3.1 Global ICSI Injection Micropipettes Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Fertility Clinics
1.3.3 Hospitals
1.3.4 Research Institutes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global ICSI Injection Micropipettes Revenue Estimates and Forecasts 2020-2031
2.2 Global ICSI Injection Micropipettes Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global ICSI Injection Micropipettes Sales Estimates and Forecasts 2020-2031
2.4 Global ICSI Injection Micropipettes Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global ICSI Injection Micropipettes Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global ICSI Injection Micropipettes Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Blunt Pipettes Market Size by Manufacturers
3.5.2 Sharp Pipettes Market Size by Manufacturers
3.5.3 Combination Pipettes Market Size by Manufacturers
3.6 Global ICSI Injection Micropipettes Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global ICSI Injection Micropipettes Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global ICSI Injection Micropipettes Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global ICSI Injection Micropipettes Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global ICSI Injection Micropipettes Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America ICSI Injection Micropipettes Sales and Revenue by Type (2020-2031)
6.4 North America ICSI Injection Micropipettes Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America ICSI Injection Micropipettes Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe ICSI Injection Micropipettes Sales and Revenue by Type (2020-2031)
7.4 Europe ICSI Injection Micropipettes Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe ICSI Injection Micropipettes Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific ICSI Injection Micropipettes Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific ICSI Injection Micropipettes Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific ICSI Injection Micropipettes Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America ICSI Injection Micropipettes Sales and Revenue by Type (2020-2031)
9.4 Central and South America ICSI Injection Micropipettes Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America ICSI Injection Micropipettes Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa ICSI Injection Micropipettes Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa ICSI Injection Micropipettes Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa ICSI Injection Micropipettes Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Kitazato
11.1.1 Kitazato Corporation Information
11.1.2 Kitazato Business Overview
11.1.3 Kitazato ICSI Injection Micropipettes Product Models, Descriptions and Specifications
11.1.4 Kitazato ICSI Injection Micropipettes Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Kitazato ICSI Injection Micropipettes Sales by Product in 2024
11.1.6 Kitazato ICSI Injection Micropipettes Sales by Application in 2024
11.1.7 Kitazato ICSI Injection Micropipettes Sales by Geographic Area in 2024
11.1.8 Kitazato ICSI Injection Micropipettes SWOT Analysis
11.1.9 Kitazato Recent Developments
11.2 Vitrolife
11.2.1 Vitrolife Corporation Information
11.2.2 Vitrolife Business Overview
11.2.3 Vitrolife ICSI Injection Micropipettes Product Models, Descriptions and Specifications
11.2.4 Vitrolife ICSI Injection Micropipettes Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Vitrolife ICSI Injection Micropipettes Sales by Product in 2024
11.2.6 Vitrolife ICSI Injection Micropipettes Sales by Application in 2024
11.2.7 Vitrolife ICSI Injection Micropipettes Sales by Geographic Area in 2024
11.2.8 Vitrolife ICSI Injection Micropipettes SWOT Analysis
11.2.9 Vitrolife Recent Developments
11.3 Synga
11.3.1 Synga Corporation Information
11.3.2 Synga Business Overview
11.3.3 Synga ICSI Injection Micropipettes Product Models, Descriptions and Specifications
11.3.4 Synga ICSI Injection Micropipettes Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Synga ICSI Injection Micropipettes Sales by Product in 2024
11.3.6 Synga ICSI Injection Micropipettes Sales by Application in 2024
11.3.7 Synga ICSI Injection Micropipettes Sales by Geographic Area in 2024
11.3.8 Synga ICSI Injection Micropipettes SWOT Analysis
11.3.9 Synga Recent Developments
11.4 Microtech
11.4.1 Microtech Corporation Information
11.4.2 Microtech Business Overview
11.4.3 Microtech ICSI Injection Micropipettes Product Models, Descriptions and Specifications
11.4.4 Microtech ICSI Injection Micropipettes Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Microtech ICSI Injection Micropipettes Sales by Product in 2024
11.4.6 Microtech ICSI Injection Micropipettes Sales by Application in 2024
11.4.7 Microtech ICSI Injection Micropipettes Sales by Geographic Area in 2024
11.4.8 Microtech ICSI Injection Micropipettes SWOT Analysis
11.4.9 Microtech Recent Developments
11.5 Sunlight Medical
11.5.1 Sunlight Medical Corporation Information
11.5.2 Sunlight Medical Business Overview
11.5.3 Sunlight Medical ICSI Injection Micropipettes Product Models, Descriptions and Specifications
11.5.4 Sunlight Medical ICSI Injection Micropipettes Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Sunlight Medical ICSI Injection Micropipettes Sales by Product in 2024
11.5.6 Sunlight Medical ICSI Injection Micropipettes Sales by Application in 2024
11.5.7 Sunlight Medical ICSI Injection Micropipettes Sales by Geographic Area in 2024
11.5.8 Sunlight Medical ICSI Injection Micropipettes SWOT Analysis
11.5.9 Sunlight Medical Recent Developments
11.6 Origio (CooperSurgical)
11.6.1 Origio (CooperSurgical) Corporation Information
11.6.2 Origio (CooperSurgical) Business Overview
11.6.3 Origio (CooperSurgical) ICSI Injection Micropipettes Product Models, Descriptions and Specifications
11.6.4 Origio (CooperSurgical) ICSI Injection Micropipettes Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Origio (CooperSurgical) Recent Developments
11.7 Hamilton Thorne
11.7.1 Hamilton Thorne Corporation Information
11.7.2 Hamilton Thorne Business Overview
11.7.3 Hamilton Thorne ICSI Injection Micropipettes Product Models, Descriptions and Specifications
11.7.4 Hamilton Thorne ICSI Injection Micropipettes Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Hamilton Thorne Recent Developments
11.8 Cook Medical
11.8.1 Cook Medical Corporation Information
11.8.2 Cook Medical Business Overview
11.8.3 Cook Medical ICSI Injection Micropipettes Product Models, Descriptions and Specifications
11.8.4 Cook Medical ICSI Injection Micropipettes Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Cook Medical Recent Developments
11.9 BioMedical Instruments
11.9.1 BioMedical Instruments Corporation Information
11.9.2 BioMedical Instruments Business Overview
11.9.3 BioMedical Instruments ICSI Injection Micropipettes Product Models, Descriptions and Specifications
11.9.4 BioMedical Instruments ICSI Injection Micropipettes Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 BioMedical Instruments Recent Developments
11.10 ASTEC Pipette
11.10.1 ASTEC Pipette Corporation Information
11.10.2 ASTEC Pipette Business Overview
11.10.3 ASTEC Pipette ICSI Injection Micropipettes Product Models, Descriptions and Specifications
11.10.4 ASTEC Pipette ICSI Injection Micropipettes Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 ASTEC Pipette Recent Developments
11.11 Cryo Bio System
11.11.1 Cryo Bio System Corporation Information
11.11.2 Cryo Bio System Business Overview
11.11.3 Cryo Bio System ICSI Injection Micropipettes Product Models, Descriptions and Specifications
11.11.4 Cryo Bio System ICSI Injection Micropipettes Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Cryo Bio System Recent Developments
11.12 Optimas
11.12.1 Optimas Corporation Information
11.12.2 Optimas Business Overview
11.12.3 Optimas ICSI Injection Micropipettes Product Models, Descriptions and Specifications
11.12.4 Optimas ICSI Injection Micropipettes Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Optimas Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 ICSI Injection Micropipettes Industry Chain
12.2 ICSI Injection Micropipettes Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 ICSI Injection Micropipettes Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 ICSI Injection Micropipettes Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 ICSI Injection Micropipettes Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global ICSI Injection Micropipettes Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global ICSI Injection Micropipettes market is projected to grow from US$ 38.72 million in 2025 to US$ 55.96 million by 2032, at a CAGR of 5.4% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-08-14
Pages: 182
USD 4900.00
(Single User License)
The global ICSI Injection Micropipettes market size was US$ 38.72 million in 2025 and is forecast to reach a readjusted size of US$ 55.96 million by 2032 with a CAGR of 5.4% during the forecast period 2026-2032.
Published Date: 2026-08-14
Pages: 160
USD 4250.00
(Single User License)
The global market for ICSI Injection Micropipettes was estimated to be worth US$ 38.72 million in 2025 and is projected to reach US$ 55.96 million, growing at a CAGR of 5.4% from 2026 to 2032.
Published Date: 2026-08-14
Pages: 160
USD 3950.00
(Single User License)
The global ICSI Injection Micropipettes market was valued at US$ 38.72 million in 2025 and is anticipated to reach US$ 55.96 million by 2032, at a CAGR of 5.4% from 2026 to 2032.
Published Date: 2026-08-14
Pages: 146
USD 2900.00
(Single User License)
The global ICSI Injection Micropipettes market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 95
USD 4250.00
(Single User License)
The global market for ICSI Injection Micropipettes was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 126
USD 3950.00
(Single User License)
The global market for ICSI Injection Micropipettes was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 90
USD 2900.00
(Single User License)
ICSI injection micropipettes are specialized, fine-tipped glass pipettes used in the intracytoplasmic sperm injection (ICSI) procedure, a common technique in in vitro fertilization (IVF). These micropipettes are meticulously crafted to have extremely fine and precise tips that can capture and inject a single sperm cell directly into an oocyte (egg cell) under a microscope. The delicate nature and precision of these micropipettes are crucial for minimizing damage to the egg during the injection process, thereby increasing the chances of successful fertilization. ICSI injection micropipettes are essential tools for embryologists, enabling them to perform the highly controlled and precise manipulations required in assisted reproductive technologies.
Published Date: 2024-05-23
Pages: 128
USD 4350.00
(Single User License)
ICSI injection micropipettes are specialized, fine-tipped glass pipettes used in the intracytoplasmic sperm injection (ICSI) procedure, a common technique in in vitro fertilization (IVF). These micropipettes are meticulously crafted to have extremely fine and precise tips that can capture and inject a single sperm cell directly into an oocyte (egg cell) under a microscope. The delicate nature and precision of these micropipettes are crucial for minimizing damage to the egg during the injection process, thereby increasing the chances of successful fertilization. ICSI injection micropipettes are essential tools for embryologists, enabling them to perform the highly controlled and precise manipulations required in assisted reproductive technologies.
Published Date: 2024-05-23
Pages: 124
USD 3950.00
(Single User License)
ICSI injection micropipettes are specialized, fine-tipped glass pipettes used in the intracytoplasmic sperm injection (ICSI) procedure, a common technique in in vitro fertilization (IVF). These micropipettes are meticulously crafted to have extremely fine and precise tips that can capture and inject a single sperm cell directly into an oocyte (egg cell) under a microscope. The delicate nature and precision of these micropipettes are crucial for minimizing damage to the egg during the injection process, thereby increasing the chances of successful fertilization. ICSI injection micropipettes are essential tools for embryologists, enabling them to perform the highly controlled and precise manipulations required in assisted reproductive technologies.
Published Date: 2024-05-23
Pages: 89
USD 2900.00
(Single User License)
The global ICSI Injection Micropipettes market is projected to grow from US$ 38.72 million in 2025 to US$ 55.96 million by 2032, at a CAGR of 5.4% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-08-14
Pages: 182
The global ICSI Injection Micropipettes market size was US$ 38.72 million in 2025 and is forecast to reach a readjusted size of US$ 55.96 million by 2032 with a CAGR of 5.4% during the forecast period 2026-2032.
Published: 2026-08-14
Pages: 160
The global market for ICSI Injection Micropipettes was estimated to be worth US$ 38.72 million in 2025 and is projected to reach US$ 55.96 million, growing at a CAGR of 5.4% from 2026 to 2032.
Published: 2026-08-14
Pages: 160
The global ICSI Injection Micropipettes market was valued at US$ 38.72 million in 2025 and is anticipated to reach US$ 55.96 million by 2032, at a CAGR of 5.4% from 2026 to 2032.
Published: 2026-08-14
Pages: 146
The global ICSI Injection Micropipettes market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 95
The global market for ICSI Injection Micropipettes was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 126
The global market for ICSI Injection Micropipettes was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 90
ICSI injection micropipettes are specialized, fine-tipped glass pipettes used in the intracytoplasmic sperm injection (ICSI) procedure, a common technique in in vitro fertilization (IVF). These micropipettes are meticulously crafted to have extremely fine and precise tips that can capture and inject a single sperm cell directly into an oocyte (egg cell) under a microscope. The delicate nature and precision of these micropipettes are crucial for minimizing damage to the egg during the injection process, thereby increasing the chances of successful fertilization. ICSI injection micropipettes are essential tools for embryologists, enabling them to perform the highly controlled and precise manipulations required in assisted reproductive technologies.
Published: 2024-05-23
Pages: 128
ICSI injection micropipettes are specialized, fine-tipped glass pipettes used in the intracytoplasmic sperm injection (ICSI) procedure, a common technique in in vitro fertilization (IVF). These micropipettes are meticulously crafted to have extremely fine and precise tips that can capture and inject a single sperm cell directly into an oocyte (egg cell) under a microscope. The delicate nature and precision of these micropipettes are crucial for minimizing damage to the egg during the injection process, thereby increasing the chances of successful fertilization. ICSI injection micropipettes are essential tools for embryologists, enabling them to perform the highly controlled and precise manipulations required in assisted reproductive technologies.
Published: 2024-05-23
Pages: 124
ICSI injection micropipettes are specialized, fine-tipped glass pipettes used in the intracytoplasmic sperm injection (ICSI) procedure, a common technique in in vitro fertilization (IVF). These micropipettes are meticulously crafted to have extremely fine and precise tips that can capture and inject a single sperm cell directly into an oocyte (egg cell) under a microscope. The delicate nature and precision of these micropipettes are crucial for minimizing damage to the egg during the injection process, thereby increasing the chances of successful fertilization. ICSI injection micropipettes are essential tools for embryologists, enabling them to perform the highly controlled and precise manipulations required in assisted reproductive technologies.
Published: 2024-05-23
Pages: 89
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now